Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company’s equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | Filing |
| 2024-03-07 12:29 pm Sale | 13G | MERRIMACK PHARMACEUTICALS INC MACK | BlackRock Inc. BLK | 715,279 4.99% | -28,344 (-3.81%) | View |
| 2024-02-14 4:20 pm Sale | 13G | MERRIMACK PHARMACEUTICALS INC MACK | 22NW Fund LP | 0 0% | -1,015,048 (Position Closed) | View |
| 2024-01-31 2:08 pm Purchase | 13G | MERRIMACK PHARMACEUTICALS INC MACK | BlackRock Inc. BLK | 743,623 5.2% | 491,029 (+194.39%) | View |
| 2024-01-25 4:05 pm Purchase | 13D | MERRIMACK PHARMACEUTICALS INC MACK | Newtyn Management LLC | 1,873,694 13.1% | 354,587 (+23.34%) | View |
| 2023-12-13 4:05 pm Purchase | 13D | MERRIMACK PHARMACEUTICALS INC MACK | Western Standard LLC | 2,220,058 15.5% | 228,950 (+11.50%) | View |
| 2023-08-14 4:05 pm Purchase | 13D | MERRIMACK PHARMACEUTICALS INC MACK | Western Standard LLC | 1,991,108 13.9% | 802,263 (+67.48%) | View |
| 2023-02-14 4:04 pm Sale | 13G | MERRIMACK PHARMACEUTICALS INC MACK | Point72 Asset Management L.P. | 0 0% | -900,981 (Position Closed) | View |
| 2023-02-13 4:20 pm Purchase | 13G | MERRIMACK PHARMACEUTICALS INC MACK | 22NW Fund LP | 1,015,048 7.6% | 1,015,048 (New Position) | View |
| 2022-08-04 4:28 pm Purchase | 13G | MERRIMACK PHARMACEUTICALS INC MACK | Point72 Asset Management L.P. | 900,981 6.7% | 900,981 (New Position) | View |
| 2022-02-14 12:50 pm Unchanged | 13G | MERRIMACK PHARMACEUTICALS INC MACK | 22NW LP | 1,241,896 9.3% | 0 (Unchanged) | View |
| 2022-02-14 08:19 am Sale | 13G | MERRIMACK PHARMACEUTICALS INC MACK | Nantahala Capital Management LLC | 569,971 4.3% | -181,872 (-24.19%) | View |
| 2021-02-12 5:13 pm Sale | 13G | MERRIMACK PHARMACEUTICALS INC MACK | DIMENSIONAL FUND ADVISORS LP | 550,539 4.1% | -122,591 (-18.21%) | View |
| 2021-02-12 4:01 pm Purchase | 13G | MERRIMACK PHARMACEUTICALS INC MACK | 22NW LP | 1,241,896 9.28% | 492,594 (+65.74%) | View |
| 2021-02-12 06:46 am Purchase | 13G | MERRIMACK PHARMACEUTICALS INC MACK | Nantahala Capital Management LLC | 751,843 5.6% | 4,208 (+0.56%) | View |
| 2020-12-02 7:21 pm Purchase | 13D | MERRIMACK PHARMACEUTICALS INC MACK | Western Standard LLC | 1,188,845 8.9% | 142,217 (+13.59%) | View |
| 2020-12-02 2:18 pm Purchase | 13D | MERRIMACK PHARMACEUTICALS INC MACK | Newtyn Management LLC | 1,519,107 11.4% | 142,227 (+10.33%) | View |
| 2020-07-24 5:42 pm Purchase | 13D | MERRIMACK PHARMACEUTICALS INC MACK | Newtyn Management LLC | 1,376,880 10.3% | 203,714 (+17.36%) | View |
| 2020-07-23 8:44 pm Purchase | 13D | MERRIMACK PHARMACEUTICALS INC MACK | Western Standard LLC | 1,046,628 7.8% | 203,715 (+24.17%) | View |
| 2020-02-14 3:17 pm Sale | 13G | MERRIMACK PHARMACEUTICALS INC MACK | BIOTECHNOLOGY VALUE FUND L P | 0 0% | -721,935 (Position Closed) | View |
| 2020-02-14 12:23 pm Purchase | 13G | MERRIMACK PHARMACEUTICALS INC MACK | Nantahala Capital Management LLC | 747,635 5.6% | 747,635 (New Position) | View |